Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florence Damond

Showing results (51-60 of 118) with videos related to

Pageof 12
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|January 30, 2007
Evaluation of the Roche Cobas TaqMan and Abbott RealTime extraction-quantification systems for HIV-1 subtypesMarie Gueudin, Jean Christophe Plantier, Véronique Lemée, et al.
The New England Journal of Medicine|April 14, 2016
Evidence of Sexual Transmission of Zika VirusEric D'Ortenzio, Sophie Matheron, Yazdan Yazdanpanah, et al.
Journal of Clinical Microbiology|July 17, 2023
Are Confirmatory Assays Reliable for HIV-1/HIV-2 Infection Differentiation? A Multicenter StudyVincent Guiraud, Jonathan Bocobza, Marion Desmonet, et al.
Nature Medicine|August 4, 2009
A new human immunodeficiency virus derived from gorillasJean-Christophe Plantier, Marie Leoz, Jonathan E Dickerson, et al.
Journal of Clinical Microbiology|July 14, 2017
New Highly Sensitive Real-Time PCR Assay for HIV-2 Group A and Group B DNA QuantificationMélanie Bertine, Marie Gueudin, Adeline Mélard, et al.
AIDS (London, England)|December 20, 2007
Prevalence of HIV-2 and HIV-1 group O infections among new HIV diagnoses in France: 2003-2006Francis Barin, Françoise Cazein, Florence Lot, et al.
Antimicrobial Agents and Chemotherapy|June 16, 2010
Baseline genotypic and phenotypic susceptibilities of HIV-1 group O to enfuvirtideAgnès Depatureaux, Charlotte Charpentier, Gilles Collin, et al.
Antiviral Therapy|September 9, 2011
Long-lasting persistence of integrase resistance mutations in HIV-2-infected patients after raltegravir withdrawalCharlotte Charpentier, Lucile Larrouy, Sophie Matheron, et al.
The Journal of Infectious Diseases|December 6, 2011
Molecular determinants of HIV-2 R5-X4 tropism in the V3 loop: development of a new genotypic toolBenoit Visseaux, Margarita Hurtado-Nedelec, Charlotte Charpentier, et al.
Antimicrobial Agents and Chemotherapy|November 9, 2011
In vitro phenotypic susceptibility of HIV-2 clinical isolates to CCR5 inhibitorsBenoit Visseaux, Charlotte Charpentier, Margarita Hurtado-Nedelec, et al.
Pageof 12

Showing results (51-60 of 118) with videos related to

Sort By:
Pageof 12
Journal of Acquired Immune Deficiency Syndromes (1999)|January 30, 2007
Evaluation of the Roche Cobas TaqMan and Abbott RealTime extraction-quantification systems for HIV-1 subtypesMarie Gueudin, Jean Christophe Plantier, Véronique Lemée, et al.
The New England Journal of Medicine|April 14, 2016
Evidence of Sexual Transmission of Zika VirusEric D'Ortenzio, Sophie Matheron, Yazdan Yazdanpanah, et al.
Journal of Clinical Microbiology|July 17, 2023
Are Confirmatory Assays Reliable for HIV-1/HIV-2 Infection Differentiation? A Multicenter StudyVincent Guiraud, Jonathan Bocobza, Marion Desmonet, et al.
Nature Medicine|August 4, 2009
A new human immunodeficiency virus derived from gorillasJean-Christophe Plantier, Marie Leoz, Jonathan E Dickerson, et al.
Journal of Clinical Microbiology|July 14, 2017
New Highly Sensitive Real-Time PCR Assay for HIV-2 Group A and Group B DNA QuantificationMélanie Bertine, Marie Gueudin, Adeline Mélard, et al.
AIDS (London, England)|December 20, 2007
Prevalence of HIV-2 and HIV-1 group O infections among new HIV diagnoses in France: 2003-2006Francis Barin, Françoise Cazein, Florence Lot, et al.
Antimicrobial Agents and Chemotherapy|June 16, 2010
Baseline genotypic and phenotypic susceptibilities of HIV-1 group O to enfuvirtideAgnès Depatureaux, Charlotte Charpentier, Gilles Collin, et al.
Antiviral Therapy|September 9, 2011
Long-lasting persistence of integrase resistance mutations in HIV-2-infected patients after raltegravir withdrawalCharlotte Charpentier, Lucile Larrouy, Sophie Matheron, et al.
The Journal of Infectious Diseases|December 6, 2011
Molecular determinants of HIV-2 R5-X4 tropism in the V3 loop: development of a new genotypic toolBenoit Visseaux, Margarita Hurtado-Nedelec, Charlotte Charpentier, et al.
Antimicrobial Agents and Chemotherapy|November 9, 2011
In vitro phenotypic susceptibility of HIV-2 clinical isolates to CCR5 inhibitorsBenoit Visseaux, Charlotte Charpentier, Margarita Hurtado-Nedelec, et al.
Pageof 12